FDA clears handheld ultrasound
A new lightweight handheld ultrasound unit may soon be on the U.S. market. The FDA has cleared for sale the Mobilsonic VUE100, a low-cost device weighing less than three pounds. The system was developed by Mobilsonic and will be distributed in the U.S.
A new lightweight handheld ultrasound unit may soon be on the U.S. market. The FDA has cleared for sale the Mobilsonic VUE100, a low-cost device weighing less than three pounds. The system was developed by Mobilsonic and will be distributed in the U.S. by Bierley Ultrasound.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
FDA Clears Ultrasound AI Detection for Pleural Effusion and Consolidation
June 18th 2025The 14th FDA-cleared AI software embedded in the Exo Iris ultrasound device reportedly enables automated detection of key pulmonary findings that may facilitate detection of pneumonia and tuberculosis in seconds.
Philips Launches Flash 5100 Point-of-Care Ultrasound System
June 17th 2025Offering a combination of intuitive touchscreen controls and enhanced image clarity, the portable Flash 5100 POC ultrasound platform reportedly facilitates confident and rapid assessment in emergency radiology and critical care settings.
